 |
|
|
|
 |
egories |
 |
|
New Addition |
|
|
|
 |
Details: |
 |
|
|
Develops new classes of diagnostic and therapeutic products for the detection, monitoring, and treatment of immune disorders and autoimmune diseases. (Nasdaq: AVAN)
|
| URL: |
|
| Title: |
|
| Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - Avant Immunotherapeutics, Inc.. Develops new classes of diagnostic and therapeutic products for the detection, monitoring, and treatment of immune disorders and autoimmune diseases. |
| Specialized in: |
|
|
|
|
|
GenPhar (Popularity:  ): Specializes in viral diagnostics, vaccines, and cancer therapy. Includes current research, news releases and contact information.
Pharmos Corporation (Popularity: ): Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
BioRexis Pharmaceutical Corp. (Popularity: ): Company with proprietary protein technology for carrier to enhance half-life and efficacy, fused peptide in therapeutic applications, and yeast host ...
Cue Biotech Inc. (Popularity: ): Company focusing on G-protein coupled receptor signaling as targets for therapeutic products. Includes corporate data, partnering and technology overviews, with ...
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
Generex Biotechnology (Popularity: ): Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
GlycoTech Corporation (Popularity: ): Research glycobiology company developing diagnostics and therapeutics for cancer and inflammatory diseases based on the interaction of glycoconjugates and their ...
Lybradyn: Microbial Natural Products (Popularity: ): Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation ...
|
|
Popular Sites |
|
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
GenPhar (Popularity: ): Specializes in viral diagnostics, vaccines, and cancer therapy. Includes current research, news releases and contact information.
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Cue Biotech Inc. (Popularity: ): Company focusing on G-protein coupled receptor signaling as targets for therapeutic products. Includes corporate data, partnering and technology overviews, with ...
BioRexis Pharmaceutical Corp. (Popularity: ): Company with proprietary protein technology for carrier to enhance half-life and efficacy, fused peptide in therapeutic applications, and yeast host ...
|
|
Related Press |
|
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ...
Newest Adult Stem Therapy Treats Diabetes (Popularity: ): In yet another advance in adult stem cell therapy, the Journal of the American Medical Association (JAMA) today released a ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis (Popularity: ): Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment has been completed in the REFLEX ...
ExonHit Builds A New Organisation (Popularity: ): ExonHit Therapeutics, a drug and diagnostic discovery company, today announced that it has created two commercial business units: the Molecular ...
|
|
Related Articles |
|
Herbal Supplements vs Prescription Drugs - The Real Score (Popularity: ): Why did I not think of that before?
Next to a sigh of relief, that is what every patient recently treated ...
How Did I End Up With Diabetes? (Popularity: ): How do you get Diabetes?
There are two main types of diabetes mellitus. These are known as type 1 and type ...
Dangers of Tap Water! (Popularity: ): Getting the cleanest water from our taps is vital. Studies have found out that pollution and deteriorating, out-of-date plumbing are ...
Treatment Centers (Popularity: ): Treatmentcenters.com provides you a list of therapists and Treatment Centers available for the same. You could locate the Treatment Centers ...
Acne Rosacea Treatment (Popularity: ): Acne Rosacea Treatment - medicinal creams are often prescribed to treat acne Rosacea. Ketoconazole, antifungal, and other creams are used ...
|
|
|
 |
|
 |
| |
| | |
|
|
|
© 2003-2008, ABC-Directory.Com. All Rights Reserved
|
|
|
 |
|
 |
|
